Edwards Lifesciences Corp.
(NYSE : EW)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -1.26%580.741.0%$908.68m
DHRDanaher Corp. -0.88%280.470.7%$763.63m
ABTAbbott Laboratories 0.87%125.790.8%$701.83m
MDTMedtronic Plc -0.51%105.570.6%$662.43m
ISRGIntuitive Surgical, Inc. -7.93%269.530.8%$484.08m
ALGNAlign Technology, Inc. -5.69%462.786.4%$357.00m
DXCMDexCom, Inc. -2.89%422.107.8%$344.00m
SYKStryker Corp. -0.89%254.741.3%$323.28m
BSXBoston Scientific Corp. -1.13%42.961.0%$311.36m
BDXBecton, Dickinson & Co. 0.19%264.471.0%$303.21m
AAgilent Technologies, Inc. -1.47%137.431.6%$228.84m
EWEdwards Lifesciences Corp. -2.56%112.600.4%$219.75m
IDXXIDEXX Laboratories, Inc. -1.80%501.963.8%$206.35m
ZBHZimmer Biomet Holdings, Inc. -0.38%122.571.7%$196.92m
PKIPerkinElmer, Inc. (United States) -0.10%174.962.4%$180.98m

Company Profile

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart, and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The Critical Care portfolio products through hemodynamic monitoring system measures a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.